Figure 3.
Effect of the APOC3 3238 G>C, the APOA5 −1131 T>C and APOA5 c.56 G>C, and the LPL c.27 G>A polymorphisms on VLDL-cholesterol levels in type III HLP patients. N represents number of type III HLP patients. *P<0.05.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.